Formation of 5alpha-reduced C19-steroids from progesterone in vitro by a pathway through 5alpha-reduced C21-steroids in ovaries of late prepubertal rats.
Ovarian homogenates from 10-150-day-old rats were incubated with [3H]progesterone and NADPH. Also, ovarian homogenates from 28-day-old rats were incubated for 5-180 min with either [14C]progesterone, [3H]5alpha-pregnane-3,20-dione or [14C]progesterone plus [3H]5alpha-pregnane-3,20-dione. Following incubation, radioactive metabolites were isolated, identified, and measured by column and paper chromatography, with derivative formation and recrystallizations to constant specific activity. Prepubertal ovaries (10, 20, and 28 days of age) converted 15-60% of progesterone to C21-17-hydroxysteroids and C19-steroids. At 40 and 150 days of age (postpubertal), the formation of these steroids decreased to less than 2%. At 10 and 150 days of age, the major C19-steroids formed from progesterone were androstenedione and testosterone. At 20 and 28 days of age, however, no accumulation of these C19-delta4-3ketosteroids was found (less than 0.1% of each), at which time the conversion of progesterone to 5alpha-reduced C19-steriods, such as androsterone and 5alpha-androstane-3alpha,17beta-diol, reached 30%. In ovaries of 28-day-old rats, the results from incubation studies for the detection of metabolic pathways indicated two biosynthetic pathways leading to 5alpha-reduced C19-steroids, one from progesterone via 5alpha-reduced C21 steroids, such as 3alpha-hydroxy-5alpha-pregnan-20-one and 3alpha,17alpha-dihydroxy-5alpha-pregnan-20-one, and a second via 17-hydroxyprogesterone, androstenedione, and testosterone. It seems that the active 5alpha-reduction of C19-delta4-3-ketosteroids and the formation of 5alpha-reduced C19-steroids by the pathway through 5alpha-reduced C21-steroids, are present in the ovaries of older prepubertal rats and may be the biological significance.
D000728:Androgens / Q000096:biosynthesis*; D000731:Androstanes / Q000096:biosynthesis; D000735:Androstenedione / Q000096:biosynthesis; D000738:Androsterone / Q000096:biosynthesis; D000818:Animals; D005260:Female; D006914:Hydroxysteroids / Q000096:biosynthesis; D007664:Ketosteroids / Q000096:biosynthesis; D010053:Ovary / Q000378:metabolism*; D011277:Pregnanediones / Q000378:metabolism; D011374:Progesterone / Q000378:metabolism*; D051381:Rats; D013739:Testosterone / Q000096:biosynthesis
D000728:Androgens; D000731:Androstanes; D006914:Hydroxysteroids; D007664:Ketosteroids; D011277:Pregnanediones; D013739:Testosterone; D000735:Androstenedione; D011374:Progesterone; D000738:Androsterone